PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors

Neuroepithelial tumors represent a heterogeneous class of human tumors including benignant and malignant tumors. The incidence of central nervous system neoplasms ranges from 3.8 to 5.1 cases per 100,000 in the population. Among malignant neuroepithelial tumors, with regard to PPAR ligands, the most extensively studied were tumors of astrocytic origin and neuroblastoma. PPARs are expressed in developing and adult neuroepithelial cells, even if with different localization and relative abundance. The majority of malignant neuroepithelial tumors have poor prognosis and do not respond to conventional therapeutic protocols, therefore, new therapeutic approaches are needed. Natural and synthetic PPAR ligands may represent a starting point for the formulation of new therapeutic approaches to be used as coadjuvants to the standard therapeutic protocols. This review will focus on the major studies dealing with PPAR expression in gliomas and neuroblastoma and the therapeutic implications of using PPAR agonists for the treatment of these neoplasms.

• Publication year

  2010

• Venue

  PPAR Research

• Publication date

  2010-03-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2010/427401PMID 20339586PMCID 2841252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid Metabolism Impairment in Human Gliomas: Expression of Peroxisomal Proteins in Human Gliomas at Different Grades of Malignancy

  2010cited by this paper
• The peroxisome proliferator-activated receptor-α (PPAR-α) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats

  2009cited by this paper
• Emerging Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in the Regulation of Neural Stem Cells Proliferation and Differentiation

  2008cited by this paper
• Biomolecular characterization of human glioblastoma cells in primary cultures: Differentiating and antiangiogenic effects of natural and synthetic PPARγ agonists

  2008cited by this paper
• Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes.

  2007cited by this paper
• Fifty hertz extremely low-frequency electromagnetic field causes changes in redox and differentiative status in neuroblastoma cells.

  2007cited by this paper
• Glioblastoma.

  2007cited by this paper
• PPARs Expression in Adult Mouse Neural Stem Cells: Modulation of PPARs during Astroglial Differentiaton of NSC

  2007cited by this paper
• The peroxisome proliferator-activated receptor-γ agonist troglitazone inhibits transforming growth factor-β–mediated glioma cell migration and brain invasion

  2007cited by this paper
• PPAR Signaling in Placental Development and Function

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• PPARβ agonists trigger neuronal differentiation in the human neuroblastoma cell line SH‐SY5Y

  2007cited by this paper
• PPARs in the brain.

  2007cited by this paper
• Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells

  2006cited by this paper
• Inhibition of in Vivo Glioma Growth and Invasion by Peroxisome Proliferator-Activated Receptor γ Agonist Treatment

  2006cited by this paper
• Recent advances in the treatment of malignant astrocytoma.

  2006cited by this paper
• Manganese Treatment Modulates the Expression of Peroxisome Proliferator-activated Receptors in Astrocytoma and Neuroblastoma Cells

  2006cited by this paper
• The potential of antidiabetic thiazolidinediones for anticancer therapy

  2006cited by this paper
• ROSIGLITAZONE MODULATES FASTING AND POST‐PRANDIAL PARAOXONASE 1 ACTIVITY IN TYPE 2 DIABETIC PATIENTS

  2006cited by this paper
• Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin

  2006cited by this paper
• From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.

  2006cited by this paper
• Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro.

  2005cited by this paper
• Peroxisome Proliferator-activated Receptor α Interacts with High Affinity and Is Conformationally Responsive to Endogenous Ligands*

  2005cited by this paper
• Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.

  2005cited by this paper
• α,β-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor γ*

  2005cited by this paper
• Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor γ ligand

  2005cited by this paper
• The Nonthiazolidinedione Tyrosine-Based Peroxisome Proliferator-Activated Receptor γ Ligand GW7845 Induces Apoptosis and Limits Migration and Invasion of Rat and Human Glioma Cells

  2005cited by this paper
• Peroxisome Proliferator-Activated Receptors (PPARs) and related transcription factors in differentiating astrocyte cultures

  2005cited by this paper
• Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma

  2005cited by this paper
• Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma.

  2005cited by this paper
• PPARγ‐dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF)

  2005cited by this paper
• Antineoplastic effects of peroxisome proliferator activated receptorγ agonists

  2005cited by this paper
• Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.

  2005cited by this paper
• Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.

  2005cited by this paper
• The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.

  2004cited by this paper
• Pilocytic Astrocytoma

  2004influential reference
• The 15-Deoxy-δ12,14-Prostaglandin J2 Inhibits the Inflammatory Response in Primary Rat Astrocytes via Down-Regulating Multiple Steps in Phosphatidylinositol 3-Kinase-Akt-NF-κB-p300 Pathway Independent of Peroxisome Proliferator-Activated Receptor γ1

  2004cited by this paper
• The PPARγ ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines

  2004cited by this paper
• Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists

  2004cited by this paper
• Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells.

  2004cited by this paper
• Acyl-CoA Synthetase 2 Overexpression Enhances Fatty Acid Internalization and Neurite Outgrowth*

  2004cited by this paper
• The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines.

  2004cited by this paper
• Glitazones Differentially Regulate Primary Astrocyte and Glioma Cell Survival

  2004cited by this paper
• Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

  2004cited by this paper
• Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.

  2004cited by this paper
• The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.

  2004cited by this paper
• Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression.

  2004cited by this paper
• Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member.

  2003cited by this paper
• Recent advances in the molecular genetics of primary gliomas

  2003cited by this paper
• Oncolytic adenoviruses for malignant glioma therapy.

  2003cited by this paper
• Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord.

  2003cited by this paper
• Localization of PPARδ in murine central nervous system: expression in oligodendrocytes and neurons

  2003cited by this paper
• Peroxisome proliferator-activated receptors β/δ: emerging roles for a previously neglected third family member

  2003cited by this paper
• 15‐Deoxy‐Δ12,14‐prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms

  2003cited by this paper
• Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas.

  2002cited by this paper
• Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.

  2002cited by this paper
• [PPARdelta and PPARgamma: roles in fatty acids signalling, implication in tumorigenesis].

  2002cited by this paper
• PPAR expression and function during vertebrate development.

  2002influential reference
• The mechanisms of action of PPARs.

  2002cited by this paper
• The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.

  2002cited by this paper
• Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription

  2002cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling

  2002cited by this paper
• Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ

  2002cited by this paper
• Immunocytochemical localization of acyl-CoA oxidase in the rat central nervous system

  2001cited by this paper
• Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways.

  2001cited by this paper
• Detailed molecular analysis of 1p36 in neuroblastoma.

  2001cited by this paper
• Differential Expression of Peroxisome Proliferator-Activated Receptors (PPARs): Tissue Distribution of PPAR-a, $3, and -y in the Adult Rat*

  2001cited by this paper
• PPAR δ agonists stimulate oligodendrocyte differentiation in tissue culture

  2001cited by this paper
• Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells.

  2001cited by this paper
• Brain and other central nervous system tumors: rates, trends, and epidemiology

  2001cited by this paper
• Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes

  2001cited by this paper
• Pathology and Genetics of Tumours of the Nervous System

  2001cited by this paper
• PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.

  2001cited by this paper
• Correlation of thrombospondin‐1 and transforming growth factor‐β expression with malignancy of glioma

  2000cited by this paper
• Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ)

  2000cited by this paper
• Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists

  2000cited by this paper
• Peroxisome proliferator-activated receptors: insight into multiple cellular functions.

  2000cited by this paper
• Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease.

  2000cited by this paper
• Expression of peroxisome proliferator‐activated receptors (PPARS) in human astrocytic cells: PPARγ agonists as inducers of apoptosis

  2000cited by this paper
• Correction for Heneka et al., Peroxisome Proliferator-Activated Receptor-γ Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell Death In Vivo

  2000cited by this paper
• Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.

  2000cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo.

  2000cited by this paper
• Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis.

  2000cited by this paper
• The PPARs: from orphan receptors to drug discovery.

  2000cited by this paper
• Presence and inducibility of peroxisomes in a human glioblastoma cell line.

  2000cited by this paper
• Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer.

  2000cited by this paper
• Pathology and genetics of tumours of the nervous system.

  2000cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell DeathIn Vivo

  2000cited by this paper
• Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase

  2000cited by this paper
• Expression of Peroxisome Proferator-Activated Receptor γ (PPARγ) in Human Transitional Bladder Cancer and its Role in Inducing Cell Death

  1999cited by this paper
• Peroxisome Proliferator-activated Receptor β Regulates Acyl-CoA Synthetase 2 in Reaggregated Rat Brain Cell Cultures*

  1999influential reference
• Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis.

  1999cited by this paper
• Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ

  1998cited by this paper
• Member of the peroxisome proliferator–activated receptor family of transcription factors is differentially expressed by oligodendrocytes

  1998cited by this paper
• Terminal differentiation of human breast cancer through PPAR gamma.

  1998cited by this paper

• Neoplastic Brain, Glioblastoma, and Immunotherapy

  2020cites this paper
• The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis

  2020cites this paper
• Oncoproteins Targeting: Antibodies, Antisense, Triple-helix. Case of Anti IGF-I Cancer Immunogene Therapy

  2019cites this paper
• Retracted: Innovative Therapies against Human Glioblastoma Multiforme

  2019cites this paper
• Twenty-Five Years of Cancer Immunogene Therapy: Anti - Gene IGF-I Approach

  2019cites this paper
• Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”

  2019cites this paper
• The Anticancer Potential of Peroxisome Proliferator‐Activated Receptor Antagonists

  2018cites this paper
• PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells

  2017cites this paper
• Effects of PPARα inhibition in head and neck paraganglioma cells

  2017cites this paper
• PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1

  2016cites this paper
• PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs

  2016cites this paper
• Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.

  2014cites this paper
• Peroxisome Morphology in Pathologies

  2014cites this paper
• Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells

  2014cites this paper
• Hypoxia modulation of peroxisome proliferator‐activated receptors (PPARs) in human glioblastoma stem cells. Implications for therapy

  2012cites this paper
• Innovative Therapies against Human Glioblastoma Multiforme

  2011cites this paper